Dietary lipids in the gastrointestinal lumen

Dietary lipids in the gastrointestinal lumen represent the primary source of exogenous fats, including triglycerides, cholesterol, and phospholipids, which are essential for energy and the absorption of fat-soluble vitamins [3, 7]. Upon ingestion, these lipids undergo a complex process of emulsification by bile acids and enzymatic hydrolysis by gastric and pancreatic lipases into absorbable components like free fatty acids and monoglycerides [3, 6]. This luminal environment is a critical site for pharmacological intervention in metabolic diseases. For instance, the drug Orlistat inhibits lipase enzymes to prevent lipid breakdown, while bile acid sequestrants and fat binders like chitosan physically interact with the luminal contents to reduce lipid absorption [2, 6]. Excessive accumulation or inefficient processing of these lipids is directly linked to the development of obesity, hyperlipidemia, and cardiovascular diseases [3, 6]. Consequently, managing the fate of dietary lipids in the GI tract is a cornerstone of therapeutic strategies for weight loss and lipid management [2, 11]. Additionally, the presence of lipids in the lumen significantly influences the bioavailability of lipophilic drugs by enhancing their solubility and facilitating lymphatic transport [1, 5]. Safety concerns associated with disrupting lipid absorption include steatorrhea and the potential for fat-soluble vitamin deficiencies [2, 6].

Other names

Dietary fatsIntestinal lipidsLuminal triglyceridesGastrointestinal lipidsDietary triglyceridesDietary cholesterol

Inhibition of lipid hydrolysis by gastric and pancreatic lipases, physical binding and sequestration of lipids or bile acids, and competition for micellar incorporation to prevent intestinal absorption.